Key result
A genetically encoded hERG PAS domain (NPAS) fully restored wild-type-like deactivation kinetics and steady-state inactivation to hERG PAS-LQT2 mutant channels in HEK293 cells.
Why the study?
Does a genetically encoded hERG PAS domain (NPAS) rescue aberrant gating in hERG PAS-LQT2 mutant channels in HEK293 cells?
Does a genetically encoded hERG PAS domain (NPAS) rescue aberrant gating in hERG PAS-LQT2 mutant channels in HEK293 cells?
A genetically encoded hERG PAS domain (NPAS) can rescue aberrant gating in hERG LQT2 mutant channels, suggesting a potential biological therapeutic approach for congenital long QT syndrome 2.
Hypothesis-generating for NPAS-based LQT2 rescue; requires in vivo validation before any therapeutic consideration.
Congenital long QT syndrome 2 (LQT2) is caused by loss-of-function mutations in the human ether-á-go-go-related gene (hERG) voltage-gated potassium (K(+)) channel. hERG channels have slow deactivation kinetics that are regulated by an N-terminal Per-Arnt-Sim (PAS) domain. Only a small percentage of hERG channels containing PAS domain LQT2 mutations (hERG PAS-LQT2) have been characterized in mammalian cells, so the functional effect of these mutations is unclear. We investigated 11 hERG PAS-LQT2 channels in HEK293 cells and report a diversity of functional defects. Most hERG PAS-LQT2 channels formed functional channels at the plasma membrane, as measured by whole cell patch clamp recordings and cell surface biotinylation. Mutations located on one face of the PAS domain (K28E, F29L, N33T, R56Q, and M124R) caused defective channel gating, including faster deactivation kinetics and less steady-state inactivation. Conversely, the other mutations caused no measurable differences in channel gating (G53R, H70R, and A78P) or no measurable currents (Y43C, C66G, and L86R). We used a genetically encoded hERG PAS domain (NPAS) to examine whether channel dysfunction could be corrected. We found that NPAS fully restored wild-type-like deactivation kinetics and steady-state inactivation to the hERG PAS-LQT2 channels. Additionally, NPAS rescued aberrant currents in hERG R56Q channels during a dynamic ramp voltage clamp. Thus, our results reveal a putative "gating face" in the PAS domain where mutations within this region form functional channels with altered gating properties, and we show that NPAS is a general means for rescuing aberrant gating in hERG LQT2 mutant channels and may be a potential biological therapeutic.
No takes yet. Share an insight, caveat, or question.
Gianulis et al. (2011) studied Congenital long QT syndrome 2 (LQT2). Genetically encoded hERG PAS domain (NPAS) vs. Uncorrected hERG PAS-LQT2 channels was evaluated on Channel gating properties (deactivation kinetics and steady-state inactivation). A genetically encoded hERG PAS domain (NPAS) fully restored wild-type-like deactivation kinetics and steady-state inactivation to hERG PAS-LQT2 mutant channels in HEK293 cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: